About Probable G-protein coupled receptor 173
Probable G-protein coupled receptor 173 (GPR173) is a protein
from Homo sapiens identified by UniProt accession
Q9NS66, 373 residues long.
MolForge cross-references it against 0 known binders and
41 disease associations.
Target properties
| Protein name | Probable G-protein coupled receptor 173 |
| UniProt accession | Q9NS66 |
| Gene | GPR173 |
| Organism | Homo sapiens |
| Length | 373 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (41)
Diseases linked to this target (Open Targets).
- Neurofibromatosis type 6 · score 0.07
- Dowling-Degos disease 1 · score 0.07
- familial progressive hyperpigmentation · score 0.07
- linear atrophoderma of Moulin · score 0.07
- familial generalized lentiginosis · score 0.07
- acroleukopathy, symmetric · score 0.07
- dyschromatosis symmetrica hereditaria · score 0.06
- Dyschromatosis universalis · score 0.06
- attention deficit hyperactivity disorder · score 0.06
- hyperpigmentation with or without hypopigmentation, familial progressive · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NS66-F1 | alphafold | PREDICTED | 81.28 | — |
Amino-acid sequence (373 residues)
MANTTGEPEE VSGALSPPSA SAYVKLVLLG LIMCVSLAGN AILSLLVLKE RALHKAPYYF LLDLCLADGI RSAVCFPFVL ASVRHGSSWT FSALSCKIVA FMAVLFCFHA AFMLFCISVT RYMAIAHHRF YAKRMTLWTC AAVICMAWTL SVAMAFPPVF DVGTYKFIRE EDQCIFEHRY FKANDTLGFM LMLAVLMAAT HAVYGKLLLF EYRHRKMKPV QMVPAISQNW TFHGPGATGQ AAANWIAGFG RGPMPPTLLG IRQNGHAASR RLLGMDEVKG EKQLGRMFYA ITLLFLLLWS PYIVACYWRV FVKACAVPHR YLATAVWMSF AQAAVNPIVC FLLNKDLKKC LRTHAPCWGT GGAPAPREPY CVM
Explore Probable G-protein coupled receptor 173 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets